Patent · US Active

Methods of using antibodies against human IL-22

US8906375B2 · kind B2 · utility

0Cited by

16References

29Claims

0Family size

Assignee

Wyeth, LLC · US

Inventors

Lynette Fouser · Acton, US
Martin Hegen · Brookline, US
Deborah Luxenberg · Melrose, US
Margot O'Toole · Newton, US

Key dates

Filing date	Nov 22, 2010
Grant date	Dec 9, 2014
Priority date	—
Expiry date	Jul 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22) and methods of using those antibodies, for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.